Page 32 - Andreaf Wainer News Today

Savant Capital LLC raised its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.5% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 106,921 shares of the healthcare product maker’s stock after buying an additional 2,595 shares during the period. Savant […]

Fermata Advisors LLC acquired a new stake in Abbott Laboratories (NYSE:ABT – Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 2,223 shares of the healthcare product maker’s stock, valued at approximately $216,000. A number of other hedge funds […]

Fort Pitt Capital Group LLC boosted its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 1.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 728,827 shares of the healthcare product maker’s stock after purchasing an additional 13,335 shares […]

Atria Investments Inc cut its holdings in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 2.7% in the third quarter, HoldingsChannel.com reports. The firm owned 130,657 shares of the healthcare product maker’s stock after selling 3,671 shares during the quarter. Atria Investments Inc’s holdings in Abbott Laboratories were worth $12,654,000 at the end of […]

Fort Pitt Capital Group LLC raised its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.9% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 728,827 shares of the healthcare product maker’s stock after purchasing an additional 13,335 shares during the period. Abbott Laboratories […]

Fermata Advisors LLC bought a new position in Abbott Laboratories (NYSE:ABT – Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 2,223 shares of the healthcare product maker’s stock, valued at approximately $216,000. A number of other hedge funds have also modified […]

Miramar Capital LLC trimmed its holdings in Abbott Laboratories (NYSE:ABT – Free Report) by 2.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 114,777 shares of the healthcare product maker’s stock after selling 2,338 shares during the period. Abbott […]

Savant Capital LLC raised its position in Abbott Laboratories (NYSE:ABT – Free Report) by 2.5% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 106,921 shares of the healthcare product maker’s stock after acquiring an additional 2,595 shares during the period. […]

Palisade Asset Management LLC increased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 0.2% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 207,608 shares of the healthcare product maker’s stock after purchasing an additional 454 shares during the period. Abbott Laboratories accounts […]

Van Cleef Asset Management Inc decreased its stake in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 11.3% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 6,000 shares of the healthcare product maker’s stock after selling 764 shares during the quarter. Van Cleef Asset Management Inc’s holdings in Abbott Laboratories were worth $581,000 […]